Twistdx Limited
Research and experimental development on biotechnology · Maidenhead
ActiveUnited KingdomIncorporated 2002Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
04523987- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2002-09-02
- Jurisdiction
- —
- Registered office
- ABBOTT HOUSE, VANWALL BUSINESS PARK, MAIDENHEAD, SL6 4XE, UNITED KINGDOM
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsFeasibility of using recombinase polymerase amplification for point of care diagnosis of Mycoplasma pneumoniae a major cause of community acquired pneumoniaLeadInnovate UK · Feasibility Studies · 2010-10-01 – 2011-09-30 · with 2 other participants£67,500awarded
Feasibility of using recombinase polymerase amplification for point of care diagnosis of Mycoplasma pneumoniae a major cause of community acquired pneumoniaLead
Innovate UK · Feasibility Studies · 2010-10-01 – 2011-09-30 · with 2 other participants
£67,500
awarded
TwistDx Limitedlead£67,500
Veterinary Laboratories Agency£31,502
Kingston University London£20,490
Development of isothermal amplification method for point of care detection of classical swine fever virus african fever virus and avain influenza virusLeadInnovate UK · Feasibility Studies · 2010-08-01 – 2011-10-31 · with 1 other participant£75,000awarded
Development of isothermal amplification method for point of care detection of classical swine fever virus african fever virus and avain influenza virusLead
Innovate UK · Feasibility Studies · 2010-08-01 – 2011-10-31 · with 1 other participant
£75,000
awarded
TwistDx Limitedlead£75,000
Veterinary Laboratories Agency£32,765
Feasibility of using recombinase polymerase amplification for a Rapid Point of Care Test for TuberculosisLeadInnovate UK · Feasibility Studies · 2010-08-01 – 2011-08-31 · with 1 other participant£51,675awarded
Feasibility of using recombinase polymerase amplification for a Rapid Point of Care Test for TuberculosisLead
Innovate UK · Feasibility Studies · 2010-08-01 – 2011-08-31 · with 1 other participant
£51,675
awarded
TwistDx Limitedlead£51,675